Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Baxter
McKesson
US Department of Justice
AstraZeneca
Queensland Health
Julphar
Moodys
Deloitte

Generated: December 12, 2018

DrugPatentWatch Database Preview

Drug Price Trends for NEVIRAPINE

« Back to Dashboard

Drug Price Trends for NEVIRAPINE

Average Pharmacy Cost for NEVIRAPINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Glossary
Drug Name NDC Price/Unit ($) Unit Date
NEVIRAPINE ER 400 MG TABLET 47781-0317-30 5.90654 EA 2018-11-21
NEVIRAPINE ER 400 MG TABLET 65862-0933-30 5.90654 EA 2018-11-21
NEVIRAPINE ER 400 MG TABLET 33342-0238-07 5.90654 EA 2018-11-21
NEVIRAPINE ER 400 MG TABLET 00781-5893-31 5.90654 EA 2018-11-21
NEVIRAPINE ER 400 MG TABLET 69097-0403-02 5.90654 EA 2018-11-21
NEVIRAPINE ER 400 MG TABLET 60505-4058-03 5.90654 EA 2018-11-21
NEVIRAPINE ER 400 MG TABLET 00378-4890-93 5.90654 EA 2018-11-21
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for NEVIRAPINE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Glossary
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
NEVIRAPINE 200MG TAB Golden State Medical Supply, Inc. 60429-0298-60 60 14.15 0.23583 EA 2018-01-01 - 2022-12-31 FSS
VIRAMUNE 200MG 14 TABLET BLISTER PACK Boehringer Ingelheim Pharmaceuticals, Inc. 00597-0046-46 14 82.61 5.90071 EA 2018-01-01 - 2020-03-31 FSS
VIRAMUNE 200MG TAB Boehringer Ingelheim Pharmaceuticals, Inc. 00597-0046-60 60 359.89 5.99817 EA 2018-01-01 - 2020-03-31 FSS
VIRAMUNE 50MG/5ML SUSP,ORAL Boehringer Ingelheim Pharmaceuticals, Inc. 00597-0047-24 240ML 95.67 0.39863 ML 2018-01-01 - 2020-03-31 FSS
VIRAMUNE XR 400MG TAB Boehringer Ingelheim Pharmaceuticals, Inc. 00597-0123-30 30 412.97 13.76567 EA 2018-01-01 - 2020-03-31 FSS
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Julphar
McKinsey
US Department of Justice
Cipla
Colorcon
US Army
Citi
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: